Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients

BACKGROUND: There is an insufficient number of reliable prognostic and response predictive biomarkers in colorectal cancer (CRC) management. In a previous study, we found that high tumour tissue expression of tumour-associated trypsin inhibitor (TATI) correlated with liver metastasis and an impaired...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gaber, Alexander, Nodin, Björn, Hotakainen, Kristina, Nilsson, Elise, Stenman, Ulf-Håkan, Bjartell, Anders, Birgisson, Helgi, Jirström, Karin
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2946315/
https://ncbi.nlm.nih.gov/pubmed/20849596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-498
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky